Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dabigatran (Pradaxa(®)): surgeon's friend or foe?

Literature DB >> 25476635

Dabigatran (Pradaxa(®)): surgeon's friend or foe?

Abstract

All clinicians, whether in primary or secondary care settings, are likely to encounter patients on this new anticoagulant. Therefore, it is imperative that clinicians are aware of the risks and benefits associated with dabigatran.

Entities: Chemical Species

Mesh：

Substances：
Antithrombins
Dabigatran

Year: 2014 PMID： 25476635 DOI： 10.1038/sj.bdj.2014.1051

Source DB: PubMed Journal: Br Dent J ISSN： 0007-0610 Impact factor: 1.626

2 in total

Review 1. Guidelines on oral anticoagulation with warfarin - fourth edition.

Authors: David Keeling; Trevor Baglin; Campbell Tait; Henry Watson; David Perry; Caroline Baglin; Steve Kitchen; Michael Makris
Journal: Br J Haematol Date: 2011-06-14 Impact factor: 6.998

2. Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran.

Authors: Michael D Ezekowitz; Stuart Connolly; Amit Parekh; Paul A Reilly; Jeanne Varrone; Susan Wang; Jonas Oldgren; Ellison Themeles; Lars Wallentin; Salim Yusuf
Journal: Am Heart J Date: 2009-05 Impact factor: 4.749

2 in total

4 in total

Dabigatran (Pradaxa(®)): surgeon's friend or foe?

Review 1. Guidelines on oral anticoagulation with warfarin - fourth edition.

2. Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran.

1. Pharmaceuticals: private prescription.

2. Newer oral anticoagulants.

3. Anticoagulants: Updates on idarucizumab.

4. Managing direct oral anticoagulants in patients undergoing dentoalveolar surgery.